- Facebook Fiasco: 10 Things Underwriters Got Wrong
- Sticker Shock: What College Is Likely to Cost in 18 Years
- Citigroup Lost $20 Million on Facebook IPO Trades
- Many Greeks Moved Their Money Abroad Long Ago
- Still Like Facebook? There’s an ETF for That.
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Main Players in the Greek Election
- Marc Faber: 100% Chance of Global Recession
- Where Large Banks Fail, Regionals are Succeeding: Bove
- Six Pack: Beer Buzz of the Week
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Big Stock Upside for Hudson City Deal: Analyst
- 5 High-Yield Stocks Ready to Boost Dividends
- Yoshikami: Four Things You Need to Know About Gold Now
- Steinbock: The Euro Zone Endgame Begins
- Option Bulls Take Another Shot on Idenix
- Top 20 European Stocks for Crisis Time: Strategist
MOST SHARED
- Under Pressure, FHA Skews to Wealthier Home Buyers
- Facebook IPO Fiasco: 10 Things Underwriters Got Wrong
- Greek Exit Could Trigger 50% Fall in Euro Stocks: Analyst
- More Fallout From the Facebook Fiasco
- Reum: Successfully Marketing Liquor through Facebook
- Greece to Exit Euro, New Currency to Fall 60%: Citi
- What College Tuition Will Look Like in 18 Years
- Marc Faber: 100% Chance of Global Recession
- What Every Investor Needs to Know About Greece
- Europe Stocks Close Broadly Flat on Greece Worries
MOST POPULAR
HOT ON FACEBOOK
European Stocks to Watch: BMW
Text Size 
Shares in BMW rose 1.7% on speculation it could buy Swedish automaker Volvo from Ford Motor, according to reports on Swedish magazine Gotenborgs Posten’s Web site citing undisclosed sources.
Shares in Ford rose 0.6%, supporting an opinion held by brokerage Merck Finck that Volvo is an under-developed brand and could hold further upside potential for any potential bidder, Dow Jones reported.
BMW is likely to be cautious however, following its previous acquisition of U.K. automaker Rover, which failed to materially help the German automaker.
Dairy Crest Group (Down 3.4%) The dairy product maker announced a recall of its butter substitute Clover, which was found to develop a bad-tasting mold usually found in blue cheese.
GlaxoSmithKline (Down 2.1%) GSK’s diabetes drug Avandia has been shunned by U.S. doctors, following a study linking the drug to heart attacks, according to early prescription data, Reuters reported.
Richemont (Up 1.6%) Kepler Equities raised its price target for the Swiss luxury goods group to $73.55 from $61.31, citing continued demand for the branded jewelry.
- The Nasdaq has suffered the most from the EU crisis showing there's risk in the usual tech stocks.
- Targeting more Millennials is just one of the items brewing for consumers in the world of spirits.
- It seems many people may need a reminder of how NOT to act on a plane. Here are a few tips.
- Here are some very unusual roadside stops along American highways that might peek your interest.
- How three generations of Americans are dealing with the finances of retirement.
Data is a real-time snapshot *Data is delayed at least 15 minutes
